Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cabazitaxel”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Testing effectiveness (Phase 2)Study completedNCT01437488
What this trial is testing

Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy

Who this might be right for
Urothelial Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Testing effectiveness (Phase 2)Study completedNCT01511536
What this trial is testing

Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sanofi 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592237
What this trial is testing

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center 120
Early research (Phase 1)Study completedNCT01379339
What this trial is testing

Cabazitaxel - PF Induction Chemotherapy

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Krzysztof Misiukiewicz 40
Testing effectiveness (Phase 2)Ended earlyNCT01365130
What this trial is testing

Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen

Who this might be right for
EsophagealGastrooesophageal CancerGastric Cancer
howard safran 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04709276
What this trial is testing

Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Neuroendocrine CarcinomaMetastatic Prostate Cancer
Andrew J. Armstrong, MD 41
Not applicableStudy completedNCT02882178
What this trial is testing

Consensus Method to Evaluate the Conformity of Prescription of a Chemotherapy

Who this might be right for
Prostate Cancer
Institut Bergonié 18
Testing effectiveness (Phase 2)Ended earlyNCT01650285
What this trial is testing

Cabazitaxel and Radiation For Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Brown University 5
Testing effectiveness (Phase 2)Study completedNCT01505868
What this trial is testing

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaLymphadenopathy+4 more
M.D. Anderson Cancer Center 170
Post-approval studies (Phase 4)Ended earlyNCT02441517
What this trial is testing

Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Global Development, Inc. 4
Large-scale testing (Phase 3)Looking for participantsNCT07213674
What this trial is testing

Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 750
Testing effectiveness (Phase 2)Study completedNCT01852578
What this trial is testing

Cabazitaxel in Relapsed and Metastatic NSCLC

Who this might be right for
NSCLC
Hellenic Oncology Research Group 46
Large-scale testing (Phase 3)Study completedNCT03295565
What this trial is testing

Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel

Who this might be right for
Prostate Cancer MetastaticMetastasis
The Netherlands Cancer Institute 100
Testing effectiveness (Phase 2)WithdrawnNCT01740570
What this trial is testing

Phase I/II Cabazitaxel for Recurrent Malignant Glioma

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT01083615
What this trial is testing

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Who this might be right for
Castrate-Resistant Prostate CancerHormone Refractory Prostate Cancer
Achieve Life Sciences 14
Testing effectiveness (Phase 2)WithdrawnNCT02035124
What this trial is testing

Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel

Who this might be right for
Advanced Prostate Cancer
SCRI Development Innovations, LLC
Early research (Phase 1)Study completedNCT01140607
What this trial is testing

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Who this might be right for
Neoplasm Malignant
Sanofi 56
Early research (Phase 1)Ended earlyNCT03043989
What this trial is testing

Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Post-approval studies (Phase 4)Study completedNCT02441894
What this trial is testing

Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Sanofi 21
Post-approval studies (Phase 4)Study completedNCT02074137
What this trial is testing

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Sanofi 10
Next Page